The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Noyes Timothy P since 2015.
This trader's CIK number is 1185035.
At the time of last reporting, Noyes Timothy P was the CHIEF EXECUTIVE OFFICER of Aerovate Therapeutics, Inc.. (stock ticker symbol AVTE).
Also see all insider trading activities at Aerovate Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | PRTO | 0 | $0 | 5,000 | $69,400 | 63,742 | $121,747 |
| 2015 | PRTO | 0 | $0 | 20,000 | $276,750 | 20,000 | $38,200 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AVTE | 0 | $0 | 41,357 | $999,876 | 40,000 | $85,600 |
| 2023 | AVTE | 0 | $0 | 81,785 | $1,692,645 | 80,000 | $171,199 |
| 2022 | AVTE | 0 | $0 | 45,000 | $810,000 | 45,000 | $96,300 |
1. Protara Therapeutics, Inc. (PRTO)
2. Aerovate Therapeutics, Inc. (AVTE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-04-12 | PRTO | Option Ex | 58,742 | 1.91 | 112,197 |
| 2016-01-04 | PRTO | Option Ex | 5,000 | 1.91 | 9,550 |
| 2016-01-04 | PRTO | Sale | 5,000 | 13.88 | 69,400 |
| 2015-12-01 | PRTO | Option Ex | 5,000 | 1.91 | 9,550 |
| 2015-12-01 | PRTO | Sale | 5,000 | 14.97 | 74,850 |
| 2015-11-02 | PRTO | Sale | 5,000 | 13.50 | 67,500 |
| 2015-11-02 | PRTO | Option Ex | 5,000 | 1.91 | 9,550 |
| 2015-10-01 | PRTO | Option Ex | 5,000 | 1.91 | 9,550 |
| 2015-10-01 | PRTO | Sale | 5,000 | 13.33 | 66,650 |
| 2015-09-08 | PRTO | Option Ex | 5,000 | 1.91 | 9,550 |
| 2015-09-08 | PRTO | Sale | 5,000 | 13.55 | 67,750 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-16 | AVTE | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-05-16 | AVTE | Sale | 10,000 | 21.72 | 217,230 |
| 2024-05-01 | AVTE | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-05-01 | AVTE | Sale | 11,357 | 20.37 | 231,376 |
| 2024-04-16 | AVTE | Sale | 10,000 | 24.67 | 246,690 |
| 2024-04-16 | AVTE | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-04-01 | AVTE | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-04-01 | AVTE | Sale | 10,000 | 30.46 | 304,580 |
| 2023-11-01 | AVTE | Sale | 1,092 | 10.42 | 11,378 |
| 2023-07-28 | AVTE | Option Ex | 5,478 | 2.14 | 11,722 |
| 2023-07-28 | AVTE | Sale | 5,478 | 18.00 | 98,604 |
| 2023-07-17 | AVTE | Option Ex | 4,522 | 2.14 | 9,677 |
| 2023-07-17 | AVTE | Sale | 4,522 | 18.11 | 81,897 |
| 2023-07-03 | AVTE | Sale | 10,000 | 18.00 | 180,000 |
| 2023-07-03 | AVTE | Option Ex | 10,000 | 2.14 | 21,400 |
| 2023-05-02 | AVTE | Sale | 693 | 21.15 | 14,656 |
| 2023-05-01 | AVTE | Sale | 15,000 | 20.61 | 309,090 |
| 2023-05-01 | AVTE | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-04-03 | AVTE | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-04-03 | AVTE | Sale | 15,000 | 19.46 | 291,945 |
| 2023-03-01 | AVTE | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-03-01 | AVTE | Sale | 15,000 | 24.22 | 363,285 |
| 2023-02-01 | AVTE | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-02-01 | AVTE | Sale | 15,000 | 22.79 | 341,790 |
| 2022-12-01 | AVTE | Option Ex | 15,000 | 2.14 | 32,100 |
| 2022-12-01 | AVTE | Sale | 15,000 | 18.00 | 270,000 |
| 2022-12-01 | AVTE | Option Ex | 15,000 | 2.14 | 32,100 |
| 2022-12-01 | AVTE | Sale | 15,000 | 18.00 | 270,000 |
| 2022-12-01 | AVTE | Option Ex | 15,000 | 2.14 | 32,100 |
| 2022-12-01 | AVTE | Sale | 15,000 | 18.00 | 270,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Noyes Timothy P (CHIEF EXECUTIVE OFFICER of Aerovate Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.